Clinical Trial Update: Serum GFAP and UCHL1: Evaluation of Their Predictive Value for SAH

View source ↗

Summary

A terminated clinical trial evaluated whether serum GFAP and UCHL1 can predict outcomes in subarachnoid hemorrhage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subarachnoid Hemorrhage

Snippet

Sponsor: The Royal Wolverhampton Hospitals NHS Trust | Conditions: Subarachnoid Haemorrhage (SAH) | Status: TERMINATED